These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Carteolol treatment of essential hypertension: a long-term study of safety and efficacy.
    Author: Luther RR, Maurath CJ, Klepper MJ, Peckinpaugh RO, Ringham GL.
    Journal: J Int Med Res; 1986; 14(4):175-84. PubMed ID: 3758467.
    Abstract:
    The long-term safety and antihypertensive efficacy of carteolol were evaluated in an open-label, multicenter trial of 245 hypertensive patients. For those patients maintained on carteolol monotherapy, three months of treatment with once-daily oral doses of carteolol ranging from 2.5 to 60 mg reduced the mean recumbent blood pressure by 12/14 mm Hg from baseline values of 151/100. Blood pressure reductions observed at three months were maintained throughout the study. The final daily dose of carteolol for most patients was 10 mg or less. Carteolol was shown to be safe and well tolerated by most patients.
    [Abstract] [Full Text] [Related] [New Search]